MedPath

Comparative evaluation of efficacy of multiple treatments in the treatment of vitiligo

Phase 3
Conditions
vitiligo.
disorder of pigmentation
Registration Number
IRCT138904081159N6
Lead Sponsor
Vice chancellor for research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Inclusion Criteria:
1- Having no treatment within past 6 months
2- Men or women of 11-60 years old
3- Have a diagnosis of vitiligo with depigmented patch more than 5 cm despite receiving at least 3 months active treatment
4- Stable vitiligo for at least 1 year
5- No infection at recipient site
6- No history of keloid and or koebner phenomenon
7- No history of active hepatitis the B, C, or AIDS
8- No pregnancy or breast-feeding
9- No active uncontrolled chronic systemic disease

Exclusion Criteria

Vitiligo patients with active or progressive disease within last 12 months.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pigmentation. Timepoint: Before intervention and 1 week, 3 weeks, 1 month and 3 months after transplantation. Method of measurement: Observation, wood lamp, visioface software.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath